Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00046501 · ClinicalTrials.gov registry record · Phase 3

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

A Phase 3 study of Diabetes Mellitus, sponsored by Sanofi.

Completed
Registry status
Phase 3
Development phase
250
Enrollment target
1
Study location

NCT00046501 is a Phase 3 study of Diabetes Mellitus that has completed, run by Sanofi. The registered enrollment target is 250 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00046501, a Phase 3 study of Diabetes Mellitus, has completed, sponsored by Sanofi.

COMPLETED
Registry status
Phase 3
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to compare the effect in blood sugar control between Lantus and twice daily intermediate acting insulins (NPH or Lente) when used as the basal insulin in a multiple daily injection setting with fast acting insulin (Lispro)

Conditions Studied

Diabetes Mellitus

Interventions

  • DRUG Lispro
  • DRUG Lantus (insulin glargine [rDNA origin] injection)
  • DRUG Humulin N
  • DRUG Humulin L

Study Locations (1)

New Jersey

  • Aventis - Bridgewater

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2002-11
Phase Phase 3

Sponsor

Sanofi

713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00046501

The ClinicalTrials.gov registry entry for NCT00046501 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 4 interventions - of which Lispro is the first listed.

NCT00046501 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00046501 about?

NCT00046501 is a clinical study titled "Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents". The purpose of the study is to compare the effect in blood sugar control between Lantus and twice daily intermediate acting insulins (NPH or Lente) when used as the basal insulin in a multiple daily injection setting with fast acting insulin (Lispro)

What is the current status of trial NCT00046501?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2002-11.

What conditions does trial NCT00046501 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00046501?

The interventions under investigation include: Lispro (DRUG), Lantus (insulin glargine [rDNA origin] injection) (DRUG), Humulin N (DRUG), Humulin L (DRUG).

Who is sponsoring clinical trial NCT00046501?

This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00046501 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.